Ferring Pharmaceuticals Secures Preferred Access for Orthopaedic & Gastroenterology Treatments Through CVS Health and Aetna Pharmacy Benefit
Posted December 18th, 2020 for Ferring Pharmaceuticals Parsippany, NJ – December 18, 2020 – Beginning January 1, 2021, Ferring Pharmaceuticals will gain preferred access through CVS Health and Aetna formularies for EUFLEXXA ® (1% sodium hyaluronate) for the treatment of knee osteoarthritis (OA) pain and exclusive preferred access on three out of four formularies for CLENPIQ ® (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for cleansing of the colon as a preparation for colonoscopy. CVS Health is the largest pharmacy health care provider in the Unit...
Source: pressreleasepoint.com